Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and nuclear receptor binding activity. Acts upstream of or within positive regulation of gene expression. Predicted to be located in intermediate filament cytoskeleton and nuclear body. Is expressed in several structures, including branchial arch; ear; genitourinary system; heart; and nervous system. Orthologous to human NR1I2 (nuclear receptor subfamily 1 group I member 2). [provided by Alliance of Genome Resources, Apr 2022]